300349 (Harmonized System 2017 for 6-digit)

About

Overview This page contains the latest trade data of Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale. In 2023, Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale were the world's 4131st most traded product, with a total trade of $179M. Between 2022 and 2023 the exports of Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale decreased by -39.9%, from $297M to $179M. Trade in Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale represent 0.00079% of total world trade.

Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale are a part of Medicaments; (not goods of heading no. 3002, 3005 or 3006) of two....

Exports In 2023 the top exporters of Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale  were Ireland ($42.8M), Romania ($33.1M), Germany ($24.6M), United States ($22.8M), and China ($13.7M).

Imports In 2023 the top importers of Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale were Hungary ($23.7M), France ($19.1M), Vietnam ($14.7M), China ($13.5M), and Sweden ($13.3M).

Ranking Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale ranks 608th in the Product Complexity Index (PCI).

Latest Data

View
Flow
Y-AXIS SCALE

The following visualization shows the latest trends on Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale. Countries are shown based on data availability.

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

Explore Latest Trends

* Trade values are converted to USD using each month's exchange rate. For December 2023 data, the exchange rate from December 30, 2023 is used.

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Exporters and Importers

Top Origin (2023)Ireland$42.8M
Top Destination (2023)Hungary$23.7M

In 2023 Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale were the world's 4131st most traded product (out of 5,380).

In 2023, the top exporters of Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale were Ireland ($42.8M), Romania ($33.1M), Germany ($24.6M), United States ($22.8M), and China ($13.7M).

In 2023, the top importers of Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale were Hungary ($23.7M), France ($19.1M), Vietnam ($14.7M), China ($13.5M), and Sweden ($13.3M).

Explore Visualizations

Exporters of Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale (2023)
[Click to Select a Country]

Importers of Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale (2023)
[Click to Select a Country]

Market Dynamics

Color
Top Origin Growth (2022 -  2023)Romania$10.1M
Top Destination Growth (2022 -  2023)Vietnam$14.5M

Between 2022 and 2023, the exports of Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale grew the fastest in Romania ($10.1M), Chinese Taipei ($2.2M), France ($1.66M), Australia ($289k), and Poland ($280k).

Between 2022 and 2023, the fastest growing importers of Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale were Vietnam ($14.5M), Egypt ($12.9M), Colombia ($2.13M), Bulgaria ($1.76M), and Brazil ($1.62M).

Explore Visualizations

Exporters of Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale (2022 - 2023)

Importers of Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale (2022 - 2023)

Market Concentration

Value

This chart shows the evolution of the market concentration of exports of Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale.

In 2023, market concentration measured using Shannon Entropy, was 3.28. This means that most of the exports of Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale are explained by 9 countries.

Explore Visualizations

Value of Exports in Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale

Net Trade

TOP NET EXPORTER (2023)Ireland$37.9M
TOP NET IMPORTER (2023)Hungary$23.6M

This map shows which countries export or import more of Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale. Each country is colored based on the difference in exports and imports of Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale during 2023.

In 2023, the countries that had a largest trade value in exports than in imports of Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale were Ireland ($37.9M), Romania ($32.7M), Germany ($18.3M), United States ($16.1M), and India ($11.7M).

In 2023, the countries that had a largest trade value in imports than in exports of Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale were Hungary ($23.6M), Vietnam ($14.7M), France ($13.9M), Sweden ($13.3M), and Egypt ($12.9M).

Net Trade (2023)

Country Comparison

Flow
Measure
Ranking

This visualization shows the countries that have an important ratio of their trade related to Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale.
It is possible to select the main countries that export or import Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale in the world, or by continent, as well as select the measure of interest.

Top 10 Exporters Countries of Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale by percentage of total exports

Product Complexity

Diversification Frontier

Specialization

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.

Relatedness vs Country Complexity (2023)

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with